| SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168  Tel: (+65) 6100 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: www.ShimClinic.com | Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration. If for STD testing, hold urine 4 hours before arriving. |
- Shim Clinic
- Procedures
- Conditions
- Drugs & products
Vaccine | Shim Clinic, Singapore |
Vaccine | Shim Clinic, Singapore: vaccine jab/shot/injection, to vaccinate against infection, to immunise against infectious disease clinic, Singapore. Private and confidential service. Definitions, references, and latest news.
Description
Vaccine types available for vaccination:
Meningococcal vaccine is recommended for persons traveling to sub-Saharan Africa, especially during the dry season (December to June), to other areas of current or recent epidemic activity, and to Mecca at any time. Particularly for the Hajj/Haj and Umrah.
If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.
STD vaccine / hepatitis vaccine shot/jab/injection to prevent some STDs
| Vaccine | Against | Disease | Age | D o s e s | Dose schedule | Price per dose (SG$) |
|---|---|---|---|---|---|---|
| Havrix™ 1440 Adult Hepatitis A vaccine | Hepatitis A virus | Hepatitis A | ≥19y | 2 | m 0 & 6-12 | $90/= |
| Engerix™-B 20 μg Hepatitis B vaccine | Hepatitis B virus | Hepatitis B | 11-15y | 2 | m 0, & 6 | $50/= |
| ≥20y | 3 | m 0, 1, & 6 | ||||
| 4 | m 0, 1, 2, & 12 or d 0, 7, 21 & m 12 | |||||
| Twinrix® | Hepatitis A virus Hepatitis B virus | Hepatitis A Hepatitis B | 1-15y | 2 | m 0, 6-12 | $120/= |
| ≥16y | 3 | m 0, 1, 6 | ||||
| 4 | d 0, 7, 21 & m 12 | |||||
| Gardasil® - HPV vaccine | HPV types 6, 11, 16 and 18 | Genital warts Cervical cancer | 9-26y | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $195/= |
| Cervarix® - HPV vaccine | HPV types 16 and 18 (31, 33, and 45) | Genital warts Cervical cancer | 10-25y | 3 | m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12 | $195/= |
| V503 - HPV vaccine | HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 | Genital warts Cervical cancer | 3 | m 0, 2, & 6 or m 0, 1, & 4 | $???/= |
References
- Vaccine - Wikipedia, the free encyclopedia
- Vaccine: Definition from Answers.com
- Vaccine - definition of Vaccine in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
- WHO | Vaccines
- Vaccines: HOME page for Vaccines and Immunizations site
Latest News
Construction of a fusion flagellin complex and evaluation of the protective immunity of it in red snapper (Lutjanus sanguineus)
Wed, 16 May 2012 16:16:06 +0100 | Letters in Applied Microbiology
Conclusions: The fusion gene flaA‐(G4S)3‐flaB from V. alginolyticus strain HY9901 was cloned by gene SOEing and was expressed in E.coli. This fusion protein FlaA‐(G4S)3‐FlaB is a good protective antigen of V.alginolyticus and should be considered as an effective vaccine candidate against infection by V.alginolyticus in red snapper.Significance and Impact of the Study: Two flagellin genes, flaA and flaB, which are independent in structure and function, were first linked together by gene SOEing technology. The finding that red snapper did adequately respond to the fusion protein FlaA‐(G4S)3‐FlaB injection made it a promising candidate for vaccine treatment. To develop effective vaccine candidates against V. alginolyticus, more attention should be given to these immunogenic ...
Nurse Immunity Awards Coincide with National Infant...
Wed, 16 May 2012 13:20:12 +0100 | NurseZone.com Nursing News
April 27, 2012 - The immunization coordinator for the Tulsa (Okla.) Health Department and a nurse educator at the Fort Hood (Texas) military base have earned the American Nurses Association’s (ANA) Immunity Award for their efforts to raise immunization rates and improve vaccine program efficiency for the populations they serve.
(Source: NurseZone.com Nursing News)
Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases
Wed, 16 May 2012 12:07:02 +0100 | International Journal of Biomedical Imaging
The performance of the interferon gamma release assays (IGRAs) and tuberculin skin test (TST) was reviewed retrospectively in patients with psoriasis, inflammatory musculoskeletal diseases, or miscellaneous inflammatory conditions. The study was carried out over a 22-month period using 109 records of patients with psoriasis (n=21), musculoskeletal disease (n=74), or other inflammatory conditions (n=14). Forty-four (48%) of 109 patients were on immunosuppressive therapy and 38/109 (35%) on systemic glucocorticoid therapy. The agreement between the IGRAs was substantial (κ=0.71) whilst that between the IGRAs and TST was low (κ=0.32). Logistic regression models revealed that IGRAs associated with risk factors for latent tuberculosis infection better than TST. TST was i...
Grandisin caused morphological changes larval and toxicity on Aedes aegypti
Wed, 16 May 2012 08:26:55 +0100 | Revista Brasileira de Farmacognosia
Dengue is a tropical disease caused by an arbovirus transmitted by Aedes aegypti. Since no effective vaccine is available for treating dengue, the present study focused on population vector control through investigating the use of the lignan grandisin, isolated from Piper solmsianum C. DC., Piperaceae, against the larvae of A. aegypti. Grandisin caused larval (L3) mortality at LC50 150 g/mL. Histological analysis on A. aegypti larvae treated with grandisin (LC50 50 g/mL) showed changes in the anterior-middle midgut, with intense tissue destruction and cell disorganization. (Source: Revista Brasileira de Farmacognosia)
Refusal of shingles vaccine: Implications for public health
Wed, 16 May 2012 08:07:35 +0100 | Journal of the American Academy of Dermatology
To the Editor: While the varicella-zoster virus (VZV; chickenpox) vaccine (Varivax) is widely utilized and has produced a dramatic decline in VZV-related morbidity and mortality, the herpes zoster virus (HZV) (shingles) vaccine (Zostavax) is used in only 2% to 7% of the target population over 50 years of age in the United States. Research has shown that the HZV vaccine is effective. A randomized, double-blind, placebo-controlled trial involving 38,546 patients 60 years of age or older demonstrated a reduction of 51.3% (P < .001) in the incidence of HZ. Furthermore, those who did develop HZ after receiving the vaccine benefited from a 66.5% (P < .001) decrease in the incidence of postherpetic neuralgia (PHN). Cost-effectiveness is more difficult to prove. Our society generally finds it acce...
Knowledge and Practices of Pig Farmers Regarding Japanese Encephalitis in Kathmandu, Nepal
Wed, 16 May 2012 04:46:32 +0100 | Zoonoses and Public Health
The objective of this study was to examine the occupational risk of pig farmers in Nepal and to determine their level of knowledge and practice of JE prevention techniques. We surveyed 100 randomly selected pig farmers in the Kathmandu District and found that pig farmers were exposed to many JE risk factors including poverty and close proximity to pigs, rice paddy fields and water birds, which are the definitive hosts for the virus. Forty‐two per cent of the farmers had heard of JE, 20% associated it with mosquito bites and 7% named pigs as risk factors. Few protective measures were taken. None of the farmers were vaccinated against JE nor were any pigs, despite an ongoing human vaccination campaign. This farming community had little ownership of land and limited education. JE education ...
US expert calls for mandatory vaccines
Wed, 16 May 2012 04:00:00 +0100 | OnMedica Latest News
DoH imms director disagrees that UK childhood jabs should be compulsoryRelated items from OnMedicaMeasles outbreak in Liverpool worsens, public health experts say Late teens urged to check their MMR status with their GPMMR vaccine hits 90% for the first time in 13 yearsParents unsure of HPV vaccine for daughters Texting can improve flu jab uptake (Source: OnMedica Latest News)
Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation
Wed, 16 May 2012 04:00:00 +0100 | Acta Paediatrica
Conclusion: Despite the marked impact of moderate to severe chronic prior GVHD on both the qualitative and quantitative T‐cell recovery post allogenic HSCT, most paediatric recipients of allogeneic stem cell grafts appear to attain protective antibody levels after immunization. (Source: Acta Paediatrica)
Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics
Wed, 16 May 2012 04:00:00 +0100 | BMC Veterinary Research - Latest articles
Conclusions:
Some amino acid substitutions in the FMDV vaccine strain genome did not have an effect on the ability of viral replication in vitro. The vaccine prepared from genetically modified FMDV by reverse genetics significantly improved the protective efficacy to the variant of the CHA topotype, compared with the wild O/HN/CHA/93 virus. Thus, the full-length cDNA clone of FMDV can be a useful tool to develop genetically engineered FMDV vaccine candidates to help control porcinophilic FMD epidemics in China. (Source: BMC Veterinary Research - Latest articles)
ABOUT TRUST ONLINE |
| Singapore Web Design by Zeus Micro | Copyrighted Material: Not for Reproduction or Distribution - Vaccine | Shim Clinic, Singapore |